Neuropeptides of human thymus in normal and pathological conditions

被引:14
作者
Mignini, F. [1 ]
Sabbatini, M. [2 ]
D'Andrea, V. [3 ]
Cavallotti, C. [4 ]
机构
[1] Univ Camerino, Scuola Sci Farmaco & Prod Salute, I-62032 Camerino, Italy
[2] Univ Piemonte Orientale, Dip Med Clin & Sperimentale, Novara, Vercelli, Italy
[3] Univ Roma La Sapienza, Dip Chirurg Gen, Rome, Italy
[4] Univ Roma La Sapienza, Dip Anat Umana, Rome, Italy
关键词
Thymoma; Myastenia Gravis; VIP; NPY; SP; NT; VASOACTIVE-INTESTINAL-PEPTIDE; ACTIVATING POLYPEPTIDES PACAP27; MYASTHENIA-GRAVIS PATIENTS; RAT THYMUS; NEUROTENSIN RECEPTORS; NERVE-FIBERS; LYMPHOCYTES; EXPRESSION; THYMOCYTES; CELLS;
D O I
10.1016/j.peptides.2011.01.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human thymus of healthy subjects and patients affected by thymoma-associated Myastenia Gravis were studied in order to visualize and compare the morphological distributive pattern of four neuropeptides: vasoactive intestinal peptide, substance P, neuropeptide V. and neurotensin. Based on our observations, we formulated hypotheses on their relations in neuro-immunomodulation under physiological and pathophysiological conditions. Immuno-histochemical staining for neuropeptides was performed and morphological and morphometrical analyses were conducted on healthy and diseased thymus. In normal thymus, a specific distributive pattern was observed for the several neuropeptide-positive nerves in different thymus lobular zones. In particular substance P-positive fibers were observed in subcapsular zone, specifically located into parenchyma, where they represent the almost total amount of fibers; neurotensin-positive fibers were observed primarily located in parenchyma than perivascular site of several thymus lobular zones, and more abundant the cortico-medullary and medullary zones. Instead VIP- and NPY-positive fibers were widely distributed in perivascular and parenchymal sites of several thymus lobular zones. In thymoma, the distribution of neuropeptide-positive fibers was quantitatively reduced, while cells immunopositive to VIP and substance P were quantitatively increased and dispersed. Observation of the perivascular and parenchymal distribution of the analyzed neuropeptides suggests evidence that a regulatory function is performed by nerves and cells that secrete neuropeptide into the thymus. The alteration of neuropeptide patterns in thymoma suggests that these neurotransmitters play a role in autoimmune diseases such as Myastenia Gravis. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:920 / 928
页数:9
相关论文
共 34 条
[1]  
ALSHAWAF AA, 1991, J ANAT, V174, P131
[2]   More sympathy for autoimmunity with neuropeptide Y? [J].
Bedoui, S ;
Miyake, S ;
Straub, RH ;
von Hörsten, S ;
Yamamura, T .
TRENDS IN IMMUNOLOGY, 2004, 25 (10) :508-512
[3]   Acetylcholinesterase activity in rat thymus after immunostimulation with interleukin β [J].
Cavallotti, D ;
Artico, M ;
Cavallotti, C ;
Iannetti, G ;
Frati, A .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2000, 182 (03) :243-248
[4]   Occurrence of adrenergic nerve fibers in human thymus during immune response [J].
Cavallotti, D ;
Artico, M ;
Iannetti, G ;
Cavallotti, C .
NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (03) :211-221
[5]   The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis [J].
Chuang, W-Y ;
Stroebel, P. ;
Belharazem, D. ;
Rieckmann, P. ;
Toyka, K. V. ;
Nix, W. ;
Schalke, B. ;
Gold, R. ;
Kiefer, R. ;
Klinker, E. ;
Opitz, A. ;
Inoue, M. ;
Kuo, T-T ;
Mueller-Hermelink, H. K. ;
Marx, A. .
GENES AND IMMUNITY, 2009, 10 (08) :667-672
[6]   UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein [J].
Day, Ian N. M. ;
Thompson, Rod J. .
PROGRESS IN NEUROBIOLOGY, 2010, 90 (03) :327-362
[7]   Neuropeptide Y effects on murine natural killer activity:: changes with ageing and cAMP involvement [J].
De la Fuente, M ;
Del Río, M ;
Víctor, VM ;
Medina, S .
REGULATORY PEPTIDES, 2001, 101 (1-3) :73-79
[8]   Vasoactive intestinal peptide in thymus: Synthesis, receptors and biological actions [J].
Delgado, M ;
Martinez, C ;
Leceta, J ;
Gomariz, RP .
NEUROIMMUNOMODULATION, 1999, 6 (1-2) :97-107
[9]   Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) protect CD4(+)CD8(+) thymocytes from glucocorticoid-induced apoptosis [J].
Delgado, M ;
Garrido, E ;
Martinez, C ;
Leceta, J ;
Gomariz, RP .
BLOOD, 1996, 87 (12) :5152-5161
[10]   PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDES (PACAP27 AND PACAP38) INHIBIT THE MOBILITY OF MURINE THYMOCYTES AND SPLENIC LYMPHOCYTES - COMPARISON WITH VIP AND IMPLICATION OF CAMP [J].
DELGADO, M ;
DELAFUENTE, M ;
MARTINEZ, C ;
GOMARIZ, RP .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 62 (02) :137-146